index - Plateforme d’immortalisation MyoLine – CRM Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

87 %

Mots clés

Allele-specific silencing therapy Fibroblast Endocytosis Myogenesis Cell Therapy Mdx52 mice Duchenne muscular dystrophy Insulin Exon skipping Computer software CDNA synthesis CMS ITSN1 LRP4 Drisapersen BMD Dynamin 2 Neuromuscular junction LTβR CXCR4 Exondys 51 BAF Autophagosome Fear response Actin CLS Duchenne Muscular Dystrophy Laminographie Human muscle stem/progenitor cells Exon Skipping Coculture Gene therapy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS DsDNA break repair FoxO Emerin Cell biology 3D co-culture Exon-skipping Antisense oligonucleotide Motor neuron Gel electrophoresis Myotube DNM2 CFTR correctors Glucose Folding-defective proteins Human Lamina-associated domain Autophagy FSHD Glucocorticoid-induced muscle atrophy Fibrosis Dominant centronuclear myopathy DM1 myoblasts Gene network analysis Flavonoid Gene Therapy Mdx Canine X-linked muscular dystrophy in Japan CXMD J Becker muscular dystrophy Lamin A/C nuclei Dystrophin CTG⋅CAGn repeat Cell-penetrating peptide Chromatin CRISPR/Cas9 Immortalized dystrophic canine myoblast Muscle Human artificial chromosomes Allele-specific silencing CXCL12 DMD Adhesion Eteplirsen Bile acid Gut microbiota ICU-acquired weakness RNA interference Adeno-associated viral vector Alternative splicing Centronuclear myopathy MT RNA/DNA Editing Skeletal muscle KLF15 Migration Immortalisation Conjugation Expanded repeats Machine learning Atrial cardiac defects Developmental biology Myotonic dystrophy Antisense morpholino Acetylcholine receptor subunit epsilon HDMD/Dmd-null mice Differentiation MSCs Clinical trial candidate screening Lymphotoxin-β-receptor